Tarsus Pharmaceuticals Inc. (TARS)
NASDAQ · Healthcare
Tarsus Pharmaceuticals Inc. Net Income 2020–2025
Tarsus Pharmaceuticals Inc. annual/quarterly net income history and growth rate from 2020 to 2026. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.
- Tarsus Pharmaceuticals Inc. net income for the quarter ending March 31, 2026 was -7.0 M, a 72.27% decrease year-over-year.
- Tarsus Pharmaceuticals Inc. net income for the twelve months ending March 31, 2026 was -65.0 M, a 50.59% decrease year-over-year.
- Tarsus Pharmaceuticals Inc. annual net income for 2025 was -66.4 M, a 42.52% decrease from 2024.
- Tarsus Pharmaceuticals Inc. annual net income for 2024 was -115.6 M, a 14.97% decrease from 2023.
- Tarsus Pharmaceuticals Inc. annual net income for 2023 was -135.9 M, a 118.86% increase from 2022.
- Tarsus Pharmaceuticals Inc. annual net income for 2022 was -62.1 M.
Net Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Tarsus Pharmaceuticals Inc. Net Income — FAQ
Tarsus Pharmaceuticals Inc. (TARS) net income over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
What is Tarsus Pharmaceuticals Inc.'s net income?
Tarsus Pharmaceuticals Inc. (TARS) reported net income of -$66M for fiscal 2025.
Where can I see TARS's net income history?
The chart and table above show Tarsus Pharmaceuticals Inc.'s net income by year and by quarter, including the growth rate.